Health
Psilocybin Therapy Shows Promise for Helping Smokers Quit
A breakthrough clinical trial suggests that psilocybin, the active compound in magic mushrooms, may be significantly more effective at helping tobacco users quit than traditional nicotine patches. Research published in JAMA Network Open indicates that, when paired with talk therapy, this psychedelic treatment offers a powerful new tool for overcoming nicotine addiction.
Study participants who received a supervised dose of psilocybin were six times more likely to remain smoke-free after six months compared to those using standard replacement patches. Experts note that while current methods like gums and medications help many, the success rates for long-term cessation remain stubbornly low for the majority of smokers.
“There was no question the psilocybin group did much better,” said Matthew Johnson, PhD, the lead author and a professor of psychiatry and behavioral sciences.
While the results are promising, researchers caution that these treatments took place in highly controlled environments with professional supervision. They hope adding psilocybin to the medical toolkit will eventually empower more individuals to successfully break the cycle of addiction and improve their long-term health.
Health Points
- Psilocybin therapy resulted in a 40% long-term success rate compared to only 10% for nicotine patches.
- The treatment was most effective when combined with 13 weeks of cognitive behavioral therapy to manage triggers.
- Experts emphasize that unsupervised use is unsafe and likely less effective than clinical administration.
Explore these resources to find the right support system for your journey toward a smoke-free lifestyle.